vs

Side-by-side financial comparison of TREACE MEDICAL CONCEPTS, INC. (TMCI) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.

TREACE MEDICAL CONCEPTS, INC. is the larger business by last-quarter revenue ($62.5M vs $35.3M, roughly 1.8× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -15.0%, a 58.9% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs -9.0%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-10.4M). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs 10.6%).

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.

TMCI vs UNTY — Head-to-Head

Bigger by revenue
TMCI
TMCI
1.8× larger
TMCI
$62.5M
$35.3M
UNTY
Growing faster (revenue YoY)
UNTY
UNTY
+33.2% gap
UNTY
24.2%
-9.0%
TMCI
Higher net margin
UNTY
UNTY
58.9% more per $
UNTY
43.9%
-15.0%
TMCI
More free cash flow
UNTY
UNTY
$54.8M more FCF
UNTY
$44.3M
$-10.4M
TMCI
Faster 2-yr revenue CAGR
UNTY
UNTY
Annualised
UNTY
17.5%
10.6%
TMCI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TMCI
TMCI
UNTY
UNTY
Revenue
$62.5M
$35.3M
Net Profit
$-9.4M
$15.5M
Gross Margin
80.6%
Operating Margin
-9.5%
55.8%
Net Margin
-15.0%
43.9%
Revenue YoY
-9.0%
24.2%
Net Profit YoY
-1775.0%
34.5%
EPS (diluted)
$-0.14
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TMCI
TMCI
UNTY
UNTY
Q4 25
$62.5M
$35.3M
Q3 25
$50.2M
$32.8M
Q2 25
$47.4M
$34.4M
Q1 25
$52.6M
$29.4M
Q4 24
$68.7M
$28.4M
Q3 24
$45.1M
$27.7M
Q2 24
$44.5M
$25.5M
Q1 24
$51.1M
$25.6M
Net Profit
TMCI
TMCI
UNTY
UNTY
Q4 25
$-9.4M
$15.5M
Q3 25
$-16.3M
$14.4M
Q2 25
$-17.4M
$16.5M
Q1 25
$-15.9M
$11.6M
Q4 24
$-501.0K
$11.5M
Q3 24
$-15.4M
$10.9M
Q2 24
$-21.2M
$9.5M
Q1 24
$-18.7M
$9.6M
Gross Margin
TMCI
TMCI
UNTY
UNTY
Q4 25
80.6%
Q3 25
79.1%
Q2 25
79.7%
Q1 25
79.7%
Q4 24
80.7%
Q3 24
80.1%
Q2 24
80.2%
Q1 24
80.2%
Operating Margin
TMCI
TMCI
UNTY
UNTY
Q4 25
-9.5%
55.8%
Q3 25
-31.2%
57.5%
Q2 25
-35.8%
62.6%
Q1 25
-29.6%
52.6%
Q4 24
-0.3%
51.0%
Q3 24
-33.6%
52.7%
Q2 24
-48.1%
49.3%
Q1 24
-37.1%
50.0%
Net Margin
TMCI
TMCI
UNTY
UNTY
Q4 25
-15.0%
43.9%
Q3 25
-32.4%
43.8%
Q2 25
-36.7%
48.0%
Q1 25
-30.3%
39.5%
Q4 24
-0.7%
40.5%
Q3 24
-34.1%
39.4%
Q2 24
-47.7%
37.1%
Q1 24
-36.5%
37.5%
EPS (diluted)
TMCI
TMCI
UNTY
UNTY
Q4 25
$-0.14
$1.52
Q3 25
$-0.26
$1.41
Q2 25
$-0.28
$1.61
Q1 25
$-0.25
$1.13
Q4 24
$-0.01
$1.13
Q3 24
$-0.25
$1.07
Q2 24
$-0.34
$0.92
Q1 24
$-0.30
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TMCI
TMCI
UNTY
UNTY
Cash + ST InvestmentsLiquidity on hand
$48.4M
Total DebtLower is stronger
$55.6M
Stockholders' EquityBook value
$87.3M
$345.6M
Total Assets
$190.6M
$3.0B
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TMCI
TMCI
UNTY
UNTY
Q4 25
$48.4M
Q3 25
$57.4M
Q2 25
$69.3M
Q1 25
$76.1M
Q4 24
$75.7M
Q3 24
$82.8M
Q2 24
$95.0M
Q1 24
$110.0M
Total Debt
TMCI
TMCI
UNTY
UNTY
Q4 25
$55.6M
Q3 25
$53.5M
Q2 25
$53.5M
Q1 25
$53.4M
Q4 24
$53.3M
$230.8M
Q3 24
$53.2M
Q2 24
$53.2M
Q1 24
$53.1M
Stockholders' Equity
TMCI
TMCI
UNTY
UNTY
Q4 25
$87.3M
$345.6M
Q3 25
$89.2M
$334.0M
Q2 25
$97.6M
$319.8M
Q1 25
$105.3M
$306.1M
Q4 24
$112.9M
$295.6M
Q3 24
$104.9M
$284.3M
Q2 24
$112.1M
$273.4M
Q1 24
$126.4M
$266.8M
Total Assets
TMCI
TMCI
UNTY
UNTY
Q4 25
$190.6M
$3.0B
Q3 25
$196.6M
$2.9B
Q2 25
$206.4M
$2.9B
Q1 25
$205.8M
$2.8B
Q4 24
$217.1M
$2.7B
Q3 24
$212.9M
$2.6B
Q2 24
$226.1M
$2.6B
Q1 24
$242.7M
$2.6B
Debt / Equity
TMCI
TMCI
UNTY
UNTY
Q4 25
0.64×
Q3 25
0.60×
Q2 25
0.55×
Q1 25
0.51×
Q4 24
0.47×
0.78×
Q3 24
0.51×
Q2 24
0.47×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TMCI
TMCI
UNTY
UNTY
Operating Cash FlowLast quarter
$-8.0M
$44.9M
Free Cash FlowOCF − Capex
$-10.4M
$44.3M
FCF MarginFCF / Revenue
-16.7%
125.7%
Capex IntensityCapex / Revenue
3.8%
1.6%
Cash ConversionOCF / Net Profit
2.90×
TTM Free Cash FlowTrailing 4 quarters
$-29.5M
$81.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TMCI
TMCI
UNTY
UNTY
Q4 25
$-8.0M
$44.9M
Q3 25
$-9.1M
$45.5M
Q2 25
$-3.0M
$-25.3M
Q1 25
$4.2M
$17.9M
Q4 24
$-4.2M
$48.0M
Q3 24
$-11.8M
$17.7M
Q2 24
$-13.9M
$-8.4M
Q1 24
$-7.2M
$15.8M
Free Cash Flow
TMCI
TMCI
UNTY
UNTY
Q4 25
$-10.4M
$44.3M
Q3 25
$-11.9M
$45.3M
Q2 25
$-7.8M
$-25.5M
Q1 25
$655.0K
$17.6M
Q4 24
$-7.3M
$47.3M
Q3 24
$-14.7M
$17.5M
Q2 24
$-15.6M
$-8.6M
Q1 24
$-11.1M
$15.7M
FCF Margin
TMCI
TMCI
UNTY
UNTY
Q4 25
-16.7%
125.7%
Q3 25
-23.7%
138.1%
Q2 25
-16.5%
-74.2%
Q1 25
1.2%
59.9%
Q4 24
-10.6%
166.5%
Q3 24
-32.6%
63.3%
Q2 24
-35.2%
-33.7%
Q1 24
-21.8%
61.4%
Capex Intensity
TMCI
TMCI
UNTY
UNTY
Q4 25
3.8%
1.6%
Q3 25
5.6%
0.7%
Q2 25
10.1%
0.5%
Q1 25
6.7%
1.0%
Q4 24
4.5%
2.4%
Q3 24
6.4%
0.5%
Q2 24
3.9%
0.5%
Q1 24
7.7%
0.3%
Cash Conversion
TMCI
TMCI
UNTY
UNTY
Q4 25
2.90×
Q3 25
3.16×
Q2 25
-1.54×
Q1 25
1.54×
Q4 24
4.17×
Q3 24
1.62×
Q2 24
-0.89×
Q1 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons